EVLO (Evelo Biosciences) Common Stock: $0.02 Mil (As of Sep. 2023)


What is Evelo Biosciences Common Stock?

Evelo Biosciences EVLO -99.00% Common Stock is $0.02 Mil as of Sep. 2023.

Evelo Biosciences's quarterly common stock declined from Mar. 2023 ($0.11 Mil) to Jun. 2023 ($0.01 Mil) but then increased from Jun. 2023 ($0.01 Mil) to Sep. 2023 ($0.02 Mil).

Evelo Biosciences's annual common stock increased from Dec. 2020 ($0.05 Mil) to Dec. 2021 ($0.05 Mil) and increased from Dec. 2021 ($0.05 Mil) to Dec. 2022 ($0.11 Mil).

Evelo Biosciences Common Stock Historical Data

* Premium members only.

The historical data trend for Evelo Biosciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evelo Biosciences Common Stock Chart

Evelo Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Common Stock
Get a 7-Day Free Trial 0.03 0.03 0.05 0.05 0.11

Evelo Biosciences Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.11 0.11 0.01 0.02

Evelo Biosciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.02 Mil mean?
Evelo Biosciences (EVLO) has a Common Stock of $0.02 Mil as of Sep. 2023. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Evelo Biosciences and its competitors.
Is Evelo Biosciences' Common Stock too high?
Evelo Biosciences' current Common Stock is $0.02 Mil.
How does Evelo Biosciences' Common Stock compare to IMNN and EDSA?
Evelo Biosciences' Common Stock of $0.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Evelo Biosciences and its competitors. Evelo Biosciences's current Common Stock is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evelo Biosciences stock overvalued right now?
Evelo Biosciences (EVLO) has a current Common Stock of $0.02 Mil. The current Common Stock is $0.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Evelo Biosciences (EVLO), the current Common Stock is $0.02 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evelo Biosciences Business Description

Address 620 Memorial Drive, Cambridge, MA, USA, 02139
Evelo Biosciences Inc is a clinical-stage biotechnology company focused on discovering and developing a new class of oral medicines that act on immune cells in the small intestine with systemic effects. The company is developing EDP1815 as a treatment in psoriasis and atopic dermatitis and EDP2939 in psoriasis.